Overview
Kazuya Ogawa practices practicing medicine in Osaka, Japan.
His clinical expertise encompasses IgG4-Related Disease, Bile Duct Obstruction, Liver Cancer, and Cholestasis.
He is actively involved in clinical research, co-authoring 22 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kazuya Ogawa
Is Kazuya Ogawa a top-rated expert for IgG4-Related Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Kazuya Ogawa is classified as an Experienced expert for IgG4-Related Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kazuya Ogawa participate in research or clinical trials?
Yes. Kazuya Ogawa has published 22 articles and abstracts on conditions like IgG4-Related Disease. You can view a list of Kazuya Ogawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bile Duct ObstructionMr. Ogawa isExperienced. Learn about Bile Duct Obstruction.
- CholestasisMr. Ogawa isExperienced. Learn about Cholestasis.
- IgG4-Related DiseaseMr. Ogawa isExperienced. Learn about IgG4-Related Disease.
- Liver CancerMr. Ogawa isExperienced. Learn about Liver Cancer.